Cargando…

Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis

BACKGROUND: An increasing body of evidence implicates both brain inflammation and oxidative stress in the pathogenesis of Alzheimer's disease (AD). The relevance of their interaction in vivo, however, is unknown. Previously, we have shown that separate pharmacological targeting of these two com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Yuemang, Chinnici, Cinzia, Tang, Hanguan, Trojanowski, John Q, Lee, Virginia MY, Praticò, Domenico
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC527877/ https://www.ncbi.nlm.nih.gov/pubmed/15500684 http://dx.doi.org/10.1186/1742-2094-1-21

Ejemplares similares

Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
por: Makani, Vishruti, et al.
Publicado: (2016)

Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model
por: Moreno-Gonzalez, Ines, et al.
Publicado: (2022)

Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer’s disease
por: Lauretti, Elisabetta, et al.
Publicado: (2017)

Isoprostane F(2α)-VI, a new marker of oxidative stress, increases following light damage to the mouse retina
por: Dentchev, Tzvete, et al.
Publicado: (2007)

Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies
por: Lou, Kevin, et al.
Publicado: (2014)

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
por: Zhang, Bin, et al.
Publicado: (2018)

Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model
por: Wang, Xu, et al.
Publicado: (2010)

Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis
por: Maarouf, Chera L, et al.
Publicado: (2013)

Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
por: Chu, Jin, et al.
Publicado: (2012)

Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer’s disease
por: Zheng, Lin, et al.
Publicado: (2016)

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
por: Guo, Jing L., et al.
Publicado: (2016)

Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer’s disease brains
por: Dudeffant, Clémence, et al.
Publicado: (2017)

Transgene distribution and immune response after ultrasound delivery of rAAV9 and PHP.B to the brain in a mouse model of amyloidosis
por: Kofoed, Rikke Hahn, et al.
Publicado: (2021)

Chronic effects of blast injury on the microvasculature in a transgenic mouse model of Alzheimer’s disease related Aβ amyloidosis
por: Clark, Alexander T., et al.
Publicado: (2022)

Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer's disease
por: Subash, Selvaraju, et al.
Publicado: (2014)

Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease
por: Wang, Lin-lin, et al.
Publicado: (2017)

Transmission and spreading of tauopathy in transgenic mouse brain
por: Clavaguera, Florence, et al.
Publicado: (2009)

Elevated levels of brain homocysteine directly modulates the pathological phenotype of a mouse model of tauopathy
por: Di Meco, Antonio, et al.
Publicado: (2018)

Amyloidosis is associated with thicker myelin and increased oligodendrogenesis in the adult mouse brain
por: Ferreira, Solène, et al.
Publicado: (2020)

α-Synuclein modulates tau spreading in mouse brains
por: Bassil, Fares, et al.
Publicado: (2020)

The 5-Lipoxygenase as a Common Pathway for Pathological Brain and Vascular Aging
por: Chu, Jin, et al.
Publicado: (2009)

Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
por: Park, Sohui, et al.
Publicado: (2021)

PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease
por: Cassano, Tommaso, et al.
Publicado: (2023)

Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment
por: Lefterov, Iliya, et al.
Publicado: (2007)

Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
por: Cornec, Anne-Sophie, et al.
Publicado: (2017)

Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer’s Disease with Plaques and Tangles
por: Chu, Jin, et al.
Publicado: (2013)

Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain
por: Kondo, Maho, et al.
Publicado: (2010)

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
por: Wang, Qing, et al.
Publicado: (2022)

TRANSGENIC MOUSE MODELS OF ALZHEIMER’S DISEASE
por: Henry-Smith, Charnae A, et al.
Publicado: (2019)

Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer’s Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
por: Rofo, Fadi, et al.
Publicado: (2021)

Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain
por: Ariga, Toshio, et al.
Publicado: (2010)

Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease
por: Jankowsky, Joanna L, et al.
Publicado: (2005)

Gene Knockout of 5-Lipoxygenase Rescues Synaptic Dysfunction and Improves Memory in the Triple-Transgenic Model of Alzheimer’s Disease
por: Giannopoulos, Phillip F., et al.
Publicado: (2013)

Blast-Mediated Traumatic Brain Injury Exacerbates Retinal Damage and Amyloidosis in the APPswePSENd19e Mouse Model of Alzheimer's Disease
por: Harper, Matthew M., et al.
Publicado: (2019)

Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice
por: Chu, Jin, et al.
Publicado: (2012)

Early‐life exposure to high‐fat diet influences brain health in aging mice
por: Di Meco, Antonio, et al.
Publicado: (2019)

Hereditary and Sporadic Forms of Aβ-Cerebrovascular Amyloidosis and Relevant Transgenic Mouse Models
por: Kumar-Singh, Samir
Publicado: (2009)

Loss of Awareness or Urinary Dysfunction? Investigating Amyloidosis and Urinary Physiology in a Transgenic Mouse
por: Hardy, Cara, et al.
Publicado: (2021)

The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease
por: Stutzbach, Lauren D, et al.
Publicado: (2013)

Modulation of inflammation in transgenic models of Alzheimer’s disease
por: Birch, Amy M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e1e2utfc94mj3dumab0m1a1rsc